Medicxi is pleased to announce the close of Medicxi Fund V, a €500 million fund dedicated to building and backing innovative biotechnology companies with clear product visions to transform patient care. The oversubscribed fund continues Medicxi’s proven asset-centric investment model, supporting world-class drug hunters and entrepreneurs across all stages of drug development – from company creation through to clinical success. Medicxi has created 16 new companies and delivered more than 20 positive clinical data readouts and since its last fundraise, has realised over $1 billion across its portfolio. Fund V will build on this momentum, further strengthening our commitment to developing focused, capital-efficient biotechnology companies that can deliver transformative therapies for patients. We are grateful to our investors for their continued trust and partnership as we advance our mission to enable the next generation of European life sciences innovation. Read more: https://lnkd.in/efhMeM8H #Medicxi #Biotech #LifeSciences #VentureCapital #FundLaunch
About us
medicxi is a Life Sciences venture capital firm, with offices in London, St. Helier (Jersey) and Geneva.
- Website
-
http://www.medicxi.com
External link for Medicxi
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Partnership
- Founded
- 2016
- Specialties
- Venture Capital and Life sciences
Locations
-
Primary
Get directions
25 Great Pulteney Street
London, W1F 9LT, GB
-
Get directions
Rue de Jargonnant 2
1207 Geneva
Geneva, CH
-
Get directions
44 Esplanade
St Helier, JE4 9WG, JE